BLOG

SARS-CoV-2 Neutralizing Antibodies discovered using upfront blocking assay

SARS-CoV-2 (COVID-19) neutralizing antibodies discovered quickly by AbTheneum

Read More +

Cell-based functional bioassays for antibodies targeting BCMA and B7-H3

Cell-based functional tests are useful to fast-forward to functional leads. Here we present data from anti-BCMA and anti-B7-H3 antibodies from AbTheneum™

Read More +

Cell-based bioassays for rapid candidate selection

Cell-based functional bioassays are a critical step in antibody development. What type of bioassays to run and when to run them can make all the difference in accelerating your antibody development.

Read More +

Why plasma cells?

Plasma cells are B cells that are secreting soluble antibodies. When an antigen is presented to a naive B cell, the cell responds by dividing rapidly. Naive B cells differentiate into plasma cells…

Read More +

AbTheneum platform

AbTheneum is SCT’s patented process for antibody discovery. Antibodies are analyzed phenotypically and genotypically from individual antibody secreting cells, examining thousands of cells simultaneously…

Read More +

Welcome to SCT’s new website!

We’ve updated our website and added this blog, to be updated with interesting applications or updates on our technology.

Check back often or join our mailing list to get updates on new blog posts and news.

Read More +